ChemoMetec Income Statement

Financials in millions DKK. Fiscal year is July - June.

Millions DKK. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Revenue	495.57	407.35	442.27	427.16	281.13
Other Revenue	-	0.52	2.13	1.23	-
Revenue	495.57	407.87	444.4	428.39	281.13
Revenue Growth (YoY)	21.50%	-8.22%	3.74%	52.38%	31.31%
Cost of Revenue	30.06	40.28	32.9	44.14	27.78
Gross Profit	465.51	367.6	411.5	384.25	253.34
Selling, General & Admin	207.46	181.42	160.47	161.36	117.71
Operating Expenses	228.99	198.63	180.94	181.4	137.32
Operating Income	236.52	168.97	230.56	202.85	116.02
Interest Expense	-0.63	-0.18	-1.09	-1.52	-0.92
Interest & Investment Income	5.9	8.08	2.46	0.01	0.09
Currency Exchange Gain (Loss)	-1.78	-0.27	-1.57	1.87	-2.46
Other Non Operating Income (Expenses)	0	-	-	0	-
EBT Excluding Unusual Items	240.01	176.59	230.36	203.22	112.73
Pretax Income	240.01	176.59	230.36	203.22	112.73
Income Tax Expense	53.61	40.3	51.69	43.75	24.38
Net Income	186.41	136.28	178.67	159.47	88.35
Net Income to Common	186.41	136.28	178.67	159.47	88.35
Net Income Growth	36.78%	-23.72%	12.04%	80.49%	49.34%
Shares Outstanding (Basic)	17	17	17	17	17
Shares Outstanding (Diluted)	17	17	17	17	17
Shares Change (YoY)	-	-	-	-	3.23%
EPS (Basic)	10.71	7.83	10.27	9.16	5.08
EPS (Diluted)	10.71	7.83	10.27	9.16	5.08
EPS Growth	36.78%	-23.73%	12.08%	80.42%	44.66%
Free Cash Flow	177.58	108.06	132.97	137.76	96.65
Free Cash Flow Per Share	10.20	6.21	7.64	7.92	5.55
Dividend Per Share	7.000	4.000	6.000	-	4.000
Dividend Growth	75.00%	-33.33%	-	-	166.67%
Gross Margin	93.93%	90.13%	92.60%	89.70%	90.12%
Operating Margin	47.73%	41.43%	51.88%	47.35%	41.27%
Profit Margin	37.61%	33.41%	40.20%	37.23%	31.43%
Free Cash Flow Margin	35.83%	26.49%	29.92%	32.16%	34.38%
EBITDA	247.68	178.78	244.49	216.65	129.01
EBITDA Margin	49.98%	43.83%	55.02%	50.57%	45.89%
D&A For EBITDA	11.17	9.82	13.93	13.8	12.98
EBIT	236.52	168.97	230.56	202.85	116.02
EBIT Margin	47.73%	41.43%	51.88%	47.35%	41.27%
Effective Tax Rate	22.34%	22.82%	22.44%	21.53%	21.63%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.